UNSPSC 51202603: Everolimus

This classification denotes a mtor inhibitor and immunosuppressant with the molecular formula C53H83NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 9HW64Q8G6G, chemically known as rapamycin, 42-o-(2-hydroxyethyl)- but more generally known as everolimus, which bears US NIH Compound Identifier 6442177. European Medicines Agency schedules Everolimus in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02065MIG.

UNSPSC 51202603 Everolimus is a Commodity code that in recent state and local solicitations covers a broader range of pharmaceutical products and medical supplies than the abstract code name suggests. State and local governments are procuring generic pharmaceuticals, over-the-counter products, naloxone, medical and first aid supplies for emergency response, and related items through both competitive sealed-bid processes and cooperative purchasing arrangements. The issuing bodies include state health and human services agencies, county health departments, municipal fire departments, and multistate cooperative purchasing alliances. Work involves managing pharmaceutical inventory, establishing direct-to-manufacturer relationships, ensuring compliance with federal manufacturing and supply-chain security standards, and delivering products to designated facilities on quarterly or as-needed schedules.

Recent activity spans multiple states and procurement vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a proposal deadline of March 26, 2026, requiring vendors to maintain relationships with authorized wholesalers and meet cGMP and Drug Supply Chain Security Act compliance. The City of Tampa issued an ITB on March 25, 2026 for medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered-market procurement exclusively for certified Small Local Business Enterprises with an estimated contract value of $700,000, due March 13, 2026. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs. Geographic activity centers on Florida, Texas, and Minnesota, with multistate cooperative purchasing expanding reach across multiple jurisdictions.